gastrointestinal
PPIs: weighing up the good and the bad
Proton pump inhibitors (PPIs) are the cornerstone of management for many gastrointestinal disorders. However, their increasingly widespread use is raising significant concerns, says Jala Moushi Proton pump inhibitors (PPIs) are …
Research Roundup
Debbie Rigby rounds up the latest in research news Efficacy of Probiotics in Irritable Bowel Syndrome A Systematic Review and Meta-analysis has concluded that some combinations of probiotics or strains …
Research Roundup
Debbie Rigby rounds up the latest in research news Deprescribing Tool for Older PeoPle with Limited-life Expectancy (De-TOPPLE) Older people with limited life expectancy (LLE) have a higher risk of …
Functional gastrointestinal disorders and irritable bowel syndrome
Functional gastrointestinal disorders (FGIDs) are common conditions seen in the pharmacy. This article will discuss the specific management of one of the most prevalent FGIDs—irritable bowel syndrome (IBS). By Lyndel …
GORD guidance: managing heartburn and regurgitation
Studies show an increase in prevalence of gastro-oesophageal reflux disease (GORD). Reviewing the symptoms and guiding on the appropriate OTC treatments can help manage the condition. Leanne Philpott investigates It’s …
Research Roundup
Debbie Rigby takes a look at the latest in research news Clinical practice guideline for deprescribing opioid analgesics This paper is a summary of the Evidence‐based clinical practice guideline for …
Research Roundup
Debbie Rigby rounds up the latest in research news Evaluating the potential outcomes of pharmacist-led activities in the Australian general practice setting A prospective observational study was conducted in eight …
Research Roundup
Debbie Rigby rounds up the latest in research news Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β2-Agonist in Patients with Chronic Obstructive Pulmonary Disease Among patients with COPD without exacerbations …
A gut feeling for good health
It’s now widely recognised that the gut and human health are intrinsically connected, and that imbalance in the gut microbiota is linked to disease, writes Leanne Philpott Key points 50% …
Reflux guidance
Managing symptoms of reflux is the topic of new quick reference guidance for pharmacists The guidance has been published by the International Pharmaceutical Federation (FIP). The guidance covers causes of reflux symptoms …
New clozapine boxed warning
More than 100 deaths have been linked to gastrointestinal disorders associated with clozapine, the TGA says The TGA has advised that a new boxed warning in the Product Information for …
Clinical tips: Irritable bowel syndrome
There are many approaches to managing irritable bowel syndrome (IBS), writes Louis Roller Irritable bowel syndrome (IBS) affects the colon (large bowel), and although it is not dangerous, it can …